| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2003 | CN1111159C Thio acid derived monocyclic N-heterocyclics as anticoagulants |
| 06/11/2003 | CN1111150C Preparing process and application of calcium levulinate |
| 06/11/2003 | CN1111068C Strong anti-oxidative composite capsule of grape seed extract OPC and its production method |
| 06/11/2003 | CN1111066C Musk plaster for bone-set |
| 06/11/2003 | CN1111059C Medicine for treating asthma |
| 06/11/2003 | CN1111056C Liquid medicine ÔÇÿFujieyeÔÇÖ" |
| 06/11/2003 | CN1111045C Chewing medicine for treating facial paralysis and its preparing process |
| 06/11/2003 | CN1111038C Chinese medicine for curing thrombotic disease |
| 06/11/2003 | CN1111034C Gel for treating tooth anaphylactia |
| 06/11/2003 | CA2367537A1 Method of alleviating the violence and stimulating the appetite of stag in the puberty age of the fall and method of promoting the growth of stag's horn |
| 06/10/2003 | US6576793 β2-adrenergic receptor agonists |
| 06/10/2003 | US6576791 Local anesthetic compounds and uses |
| 06/10/2003 | US6576784 Antiviral agents |
| 06/10/2003 | US6576776 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/10/2003 | US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors |
| 06/10/2003 | US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide |
| 06/10/2003 | US6576752 Aminooxy functionalized oligomers |
| 06/10/2003 | US6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor |
| 06/10/2003 | US6576675 Such as 4-fluorostyryl-4-iodobenzylsulfone; targeting receptor tyrosine kinases |
| 06/10/2003 | US6576674 Aquacidal compound comprising an anthraquinone; particularly effective for treating ballast water of ships or other enclosed volumes of water to control the relocation of plants, toxic bacteria, and animals contained in the water. |
| 06/10/2003 | US6576673 Encapsulating isophorone in high strength matrix containing acrylic resin and ceramic particles to prevent easy removal; increased wood protection |
| 06/10/2003 | US6576672 Parkingson's Disease and dementias characterized by mito-chondrial damage; such as 3,7-diazanonane-1,9-diamine; neutralizing dopamine depriving effect |
| 06/10/2003 | US6576671 Left ventricular dysfunction; 5,6-dihydroxy- or 5,6-diiso-butyroloxy-2-methylaminotetralin |
| 06/10/2003 | US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt |
| 06/10/2003 | US6576669 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes |
| 06/10/2003 | US6576668 Remedies for arthrosis deformans |
| 06/10/2003 | US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 06/10/2003 | US6576665 Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
| 06/10/2003 | US6576663 6-Keto prostaglandin F1α and analogs for treating dry eye |
| 06/10/2003 | US6576661 Active ingredient combination having insecticidal and acaricidal characteristics |
| 06/10/2003 | US6576660 Methods and compositions for regulation of 5-α-reductase activity |
| 06/10/2003 | US6576659 Use of oxandrolone in the treatment of burns an other wounds |
| 06/10/2003 | US6576658 Compositions and uses of dictyostatin compounds |
| 06/10/2003 | US6576657 Amidino derivatives and their use as thrombin inhibitors |
| 06/10/2003 | US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser |
| 06/10/2003 | US6576655 To produce polymers; cancer therapy |
| 06/10/2003 | US6576654 Method for the treatment of cystic fibrosis |
| 06/10/2003 | US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 06/10/2003 | US6576652 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension. |
| 06/10/2003 | US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
| 06/10/2003 | US6576650 No central nervous system side effects |
| 06/10/2003 | US6576649 Method for treating pharmaceutical compositions |
| 06/10/2003 | US6576648 Compound with growth hormone releasing properties |
| 06/10/2003 | US6576647 Anticancer agents; cyclin dependent kinase inhibitors; improved physical properties, storage stability; materials handling |
| 06/10/2003 | US6576646 Administering cholinesterase inhibitor |
| 06/10/2003 | US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 06/10/2003 | US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP) |
| 06/10/2003 | US6576641 For therapy and prophylaxis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), or a neurodegenerative disease of the eye, including photoreceptor loss in retina |
| 06/10/2003 | US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease |
| 06/10/2003 | US6576638 Use of substance P antagonists in the treatment of the adenocarcinomas |
| 06/10/2003 | US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, |
| 06/10/2003 | US6576636 Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| 06/10/2003 | US6576635 Compositions comprising trimetrexate |
| 06/10/2003 | US6576630 Compounds and compositions as protease inhibitors |
| 06/10/2003 | US6576628 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis |
| 06/10/2003 | US6576626 Treating gastro-oesophageal reflux disease |
| 06/10/2003 | US6576624 Administering domperidone or pimozide jointly with miltefo-sine; reducing side effect of decrease in body weight |
| 06/10/2003 | US6576622 3'-azido-3'-deoxythymidine and floxuridine; acquired immunodeficiency syndrome |
| 06/10/2003 | US6576621 Preparation of thioarabinofuranosyl compounds and use thereof |
| 06/10/2003 | US6576619 Orally active A1 adenosine receptor agonists |
| 06/10/2003 | US6576612 Intravenous administration of an alpha halogen acryloyl distamycin derivative |
| 06/10/2003 | US6576609 Methods and compositions for generating angiostatin |
| 06/10/2003 | US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell |
| 06/10/2003 | US6576466 Activation; separation |
| 06/10/2003 | US6576464 Methods for providing differentiated stem cells |
| 06/10/2003 | US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions |
| 06/10/2003 | US6576436 Anticancer agents based on prevention of protein prenylation |
| 06/10/2003 | US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis |
| 06/10/2003 | US6576274 Controlled ethanolic extraction, drying, and processing by supercritical fluid extractions |
| 06/10/2003 | US6576272 Citrus aurantium extract and a methylxanthine, with or without St. John's wort extract and L- Phenylalanine for controlling weight wherein fat is lost and lean body mass preserved. |
| 06/10/2003 | US6576271 Method for inhibiting inflammation using bioflavonoids |
| 06/10/2003 | US6576267 Composition and method for treating the effects of diseases and maladies |
| 06/10/2003 | US6576264 Insoluble drug delivery |
| 06/10/2003 | US6576261 Potentiation of inclusion complex formation of cyclodextrin derivatives |
| 06/10/2003 | US6576260 Sustained-release form of administration containing tramadol saccharinate |
| 06/10/2003 | US6576259 Sustained release formulations containing tacrolimus |
| 06/10/2003 | US6576258 Anhydrous granulation of active substances and dried pharmaceutically acceptable auxiliary substances for the preparation of pellet cores or granules, drug delivery |
| 06/10/2003 | US6576256 Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| 06/10/2003 | US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group |
| 06/10/2003 | US6576250 Administering in rectum of mammal dosage form comprising therapeutically effective amount of active ingredient and at least one effervescent penetration enhancer sufficient to increase absorption across mucosa layer of target area |
| 06/10/2003 | US6576248 Pigmented vitamin C composition |
| 06/10/2003 | US6576242 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| 06/10/2003 | US6576230 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones |
| 06/10/2003 | US6576229 Administering synthetic phenolic polymeric material prepared by dissolving phenolic compound in aqueous solution, adjusting pH to between 8 and 11, oxidizing, polymerizing, adding water soluble compound, removing low molecular weight material |
| 06/10/2003 | US6576219 Administration directly to eye of compounds that inhibit function of a Na+- K+-2Cl-2 cotransporter mechanism discovered in trabecular meshwork cells of mammalian eyes |
| 06/10/2003 | US6576218 Transplacental delivery of oligonucleotides |
| 06/10/2003 | CA2413024A1 Antipyretic preparation containing xylitol |
| 06/10/2003 | CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| 06/10/2003 | CA2303577C Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death |
| 06/10/2003 | CA2284753C Throat soothing compositions |
| 06/10/2003 | CA2265708C Lipoxin compounds and their use in treating cell proliferative disorders |
| 06/10/2003 | CA2245896C A therapeutic agent for renal disease |
| 06/10/2003 | CA2232775C Acyl compounds |
| 06/10/2003 | CA2225286C A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 06/10/2003 | CA2225156C Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
| 06/10/2003 | CA2216277C Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 06/10/2003 | CA2204437C Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/10/2003 | CA2200651C Sodium alendronate preparation for local administration |
| 06/10/2003 | CA2192354C Corticotropin releasing factor against antagonist |
| 06/10/2003 | CA2191795C Antisense oligonucleotide modulation of raf gene expression |